Image de couverture de livre

Cachexia and Type 2 Diabetes Mellitus Are Independent Factors for Mortality in Patients With Cirrhosis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Takao Miwa, Goki Suda, Ryosuke Tateishi, Tatsunori Hanai, Masatsugu Ohara, Yasuhiro Hagiwara, Shinji Unome, Kazuya Okushin, Mina Nakagawa, Naoya Sakamoto, Masahito Shimizu
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Hepatology Research
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cachexia in Cirrhosis Is Characterized by Sex‐Specific Loss of Muscle Mass and Adipose Tissue
par: Takao Miwa, et autres
Publié: (2025)

Cachexia is an independent predictor of mortality in patients with cirrhosis
par: Takao Miwa, et autres
Publié: (2025)

Altered Serum Bile Acid Pattern as an Independent Factor for Covert and Overt Hepatic Encephalopathy in Patients With Cirrhosis
par: Takao Miwa, et autres
Publié: (2025)

Correlations Between Serum Bile Acids and Ammonia Levels in Patients With Cirrhosis
par: Takao Miwa, et autres
Publié: (2025)

Animal Naming Test Can Identify Covert Hepatic Encephalopathy in Patients With Cirrhosis With Limited Influence From Age or Educational Level
par: Takao Miwa, et autres
Publié: (2025)

Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma
par: Kenji Imai, et autres
Publié: (2025)

A case of A20 haploinsufficiency complicated by autoimmune hepatitis
par: Taisei Iwasa, et autres
Publié: (2024)

Subcutaneous Adipose Tissue Accumulation is Associated With an Improved Prognosis in Patients With Hepatocellular Carcinoma
par: Kenji Imai, et autres
Publié: (2026)

Response to “Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma”
par: Kenji Imai, et autres
Publié: (2026)

Is Glucose Intolerance a Precursor of Cachexia in Patients With Liver Cirrhosis?
par: Tsutomu Nishida, et autres
Publié: (2025)

Applying Cachexia Criteria to Cirrhosis: Considerations for Appropriate Interpretation and Future Research
par: Atsushi Nakamura
Publié: (2025)

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease
par: Masaya Sato, et autres
Publié: (2026)

Etiological changes of liver cirrhosis and hepatocellular carcinoma‐complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021
par: Hirayuki Enomoto, et autres
Publié: (2024)

Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
par: Zijian Yang, et autres
Publié: (2024)

Response to “Letter to the Editor: Pre‐Treatment Liver Stiffness is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication”
par: Takuma Nakatsuka, et autres
Publié: (2025)

Differential peripheral memory T cell subsets sensitively indicate the severity of nonalcoholic fatty liver disease
par: Akira Kado, et autres
Publié: (2024)

Individualized Effects of Weight Gain in Adulthood on the Development of MASLD in Japanese Non‐Obese Individuals
par: Kaiji Fukamizo, et autres
Publié: (2025)

Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination
par: Yuta Myojin, et autres
Publié: (2025)

Real‐world trends in acute viral hepatitis in Japan: A nationwide questionnaire‐based survey
par: Kazuya Okushin, et autres
Publié: (2024)

Clinical course of small gastric subepithelial lesion less than 20 mm diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration
par: Ryosuke Kobayashi, et autres
Publié: (2024)

Treatment of liver cirrhosis in the era of steatotic liver disease
par: Masahito Shimizu
Publié: (2024)

Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan
par: Yasue Takeuchi, et autres
Publié: (2024)

Factors involved in gastroesophageal varix‐related events in patients with hepatitis C virus‐related compensated and decompensated cirrhosis after direct‐acting antiviral therapy
par: Yuki Tahata, et autres
Publié: (2024)

Elevation of Immunoglobulin Free Light Chain and BAFF Levels Associated With Immune Activation Predicts Survival Rates in Chronic Liver Disease
par: Motoh Iwasa, et autres
Publié: (2025)

Guidance for Liver Rehabilitation in Chronic Liver Disease
par: Shuji Terai, et autres
Publié: (2026)

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study
par: Federica Lo Prinzi, et autres
Publié: (2025)

Genetic alterations in hepatocellular carcinoma after sustained virological response in relation to the molecular characterization of metabolic diseases
par: Fukiko Kawai‐Kitahata, et autres
Publié: (2025)

Differential Eligibility for Immune Checkpoint Inhibitor‐Based Therapy at Recurrence: A Potential Explanation for Improved Survival in Viral Hepatocellular Carcinoma
par: Kazuya Kariyama, et autres
Publié: (2026)

Comment on “Using Serum Creatinine‐to‐Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis”
par: Weiming Wang, et autres
Publié: (2026)

Impact of Early‐Line Systemic Therapies on Liver Function in Hepatocellular Carcinoma: Longitudinal Change of ALBI Score and Ammonia Level With and Without Anti‐VEGF Agents
par: Naoshi Nishida, et autres
Publié: (2026)

ALDH2 Polymorphism in Alcohol‐Related Cirrhosis Requiring Liver Transplantation: A Recipient–Donor Analysis
par: Noriyo Yamashiki, et autres
Publié: (2026)

Obesity Decreases Liver‐Related Death in Patients With Cirrhosis: A Retrospective Propensity Score‐Matched Study
par: Kei Endo, et autres
Publié: (2025)

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis
par: Tomomi Ozaki, et autres
Publié: (2024)

Nationwide Trends in Liver Stiffness Measurement in Japan: A Real‐World Evidence of NILDA Using the National Database of Health Insurance Claims
par: Masahito Nakano, et autres
Publié: (2025)

Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease
par: Masahito Nakano, et autres
Publié: (2024)

Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications
par: Mina Komuta, et autres
Publié: (2025)

Letter to the Editor: “Altered Serum Bile Acid Pattern as an Independent Factor for Covert and Overt Hepatic Encephalopathy in Patients With Cirrhosis”
par: Yumin Guo, et autres
Publié: (2025)

Cirrhosis Is an Independent Risk Factor for Mortality in Ischemic Stroke—A Nationwide Analysis
par: Kayode E. Ogunniyi, et autres
Publié: (2025)

Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study
par: Khaled Al-Smadi, et autres
Publié: (2024)

LC‐Pred: A Transformer‐Based Interactive Interface for Liver Cirrhosis Prediction
par: Bisweswari Rath, et autres
Publié: (2026)